With respect to a tumor-suppressive role of SIRT6, the loss of SIRT6 stimulated the progression of hepatocellular carcinoma [46], and lower expression of SIRT6 was associated with poor prognosis in breast cancer patients [23]. Here, SIRT6 is linked to breast carcinoma.